QLN

Extracorporeal System For Carbon Dioxide Removal For The Treatment Of Covid-19

Product code
QLN
Device name
Extracorporeal System For Carbon Dioxide Removal For The Treatment Of Covid-19
Device class
Class N
Medical specialty
Unknown
Marketing pathway
EUA - Emergency Use Authorization
Flag
Life-sustaining / life-supporting

FDA classification definition

to treat lung failure due to COVID-19 when used as an adjunct to noninvasive or invasive mechanical ventilation in reducing hypercapnia and hypercapnic acidosis due to Coronavirus Disease 2019 (COVID-19), and/or maintaining normalized levels of partial pressure of carbon dioxide (PCO2) and pH in patients suffering from acute, reversible respiratory failure due to COVID-19 for whom ventilation of CO2 cannot be adequately, safely, or tolerably achieved.

Definition text from the FDA device classification database (U.S. federal government work, public domain).

Official FDA classification page: QLN
Classification and pathway per current FDA publications. Data from openFDA (CC0).